| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | TAE684 | GDSC1000 | pan-cancer | AAC | -0.19 | 0.001 |
| mRNA | Erlotinib | GDSC1000 | pan-cancer | AAC | -0.18 | 0.0006 |
| mRNA | BRD-K29086754 | CTRPv2 | pan-cancer | AAC | -0.17 | 0.04 |
| mRNA | blebbistatin | CTRPv2 | pan-cancer | AAC | -0.17 | 0.04 |
| mRNA | QS11 | CTRPv2 | pan-cancer | AAC | -0.17 | 0.04 |
| mRNA | GSK1120212 | CTRPv2 | pan-cancer | AAC | -0.16 | 0.003 |
| mRNA | lapatinib | GDSC1000 | pan-cancer | AAC | -0.15 | 0.004 |
| mRNA | Nutlin-3a (-) | GDSC1000 | pan-cancer | AAC | -0.15 | 0.0002 |
| mRNA | 17-AAG | CCLE | pan-cancer | AAC | -0.14 | 0.004 |
| mRNA | FSC231 | CTRPv2 | pan-cancer | AAC | -0.14 | 0.08 |